We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
Cap. Flow
-$786M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.5M
2
INDA icon
iShares MSCI India ETF
INDA
+$9.67M
3
IBKC
IBERIABANK Corp
IBKC
+$8.93M
4
HYT icon
BlackRock Corporate High Yield Fund
HYT
+$8.03M
5
AMZN icon
Amazon
AMZN
+$7.15M

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$16.7M
2
NFLX icon
Netflix
NFLX
+$15.8M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$15.7M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$15.1M
5
MDCO
Medicines Co
MDCO
+$11.9M

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Consumer Discretionary 3.94%
3 Healthcare 3.91%
4 Communication Services 2.7%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPOP icon
876
Popular Inc
BPOP
$11.2B
$30K ﹤0.01%
867
-2,899
-77% -$144K
GILD icon
877
CALL
Gilead Sciences
GILD
$168B
$30K ﹤0.01%
400
-500
-56% -$34.5K
J icon
878
Jacobs Solutions
J
$17.3B
$30K ﹤0.01%
463
-3,870
-89% -$291K
LII icon
879
Lennox International
LII
$14.9B
$30K ﹤0.01%
165
-129
-44% -$29.8K
MFC icon
880
Manulife Financial
MFC
$72.7B
$30K ﹤0.01%
2,429
+140
+6% +$2.43K
SPPI
881
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$30K ﹤0.01%
12,678
+3,847
+44% +$10.5K
ARD
882
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$30K ﹤0.01%
+2,545
New +$44.7K
AIN icon
883
Albany International
AIN
$1.79B
$29K ﹤0.01%
611
-1,397
-70% -$91.5K
ARWR icon
884
CALL
Arrowhead Research
ARWR
$12.6B
$29K ﹤0.01%
+1,000
New +$40.3K
BIB icon
885
ProShares Ultra NASDAQ Biotechnology
BIB
$87.9M
$29K ﹤0.01%
+621
New +$34.6K
CYTK icon
886
Cytokinetics
CYTK
$10.6B
$29K ﹤0.01%
2,469
-5,465
-69% -$69.7K
DIS icon
887
PUT
Walt Disney
DIS
$179B
$29K ﹤0.01%
300
-36,700
-99% -$4.64M
SRPT icon
888
CALL
Sarepta Therapeutics
SRPT
$1.92B
$29K ﹤0.01%
300
– –
XYL icon
889
Xylem
XYL
$28.8B
$29K ﹤0.01%
449
-1,717
-79% -$135K
RSX
890
DELISTED
VanEck Russia ETF
RSX
$29K ﹤0.01%
+1,748
New +$39K
ALXN
891
DELISTED
Alexion Pharmaceuticals
ALXN
$29K ﹤0.01%
326
-2,247
-87% -$221K
BALY icon
892
Bally's
BALY
$635M
$28K ﹤0.01%
+2,175
New +$50.1K
BF.B icon
893
Brown-Forman Class B
BF.B
$12.9B
$28K ﹤0.01%
500
-28
-5% -$1.8K
DBC icon
894
Invesco DB Commodity Index Tracking Fund
DBC
$1.72B
$28K ﹤0.01%
+2,492
New +$34.8K
DIA icon
895
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
$28K ﹤0.01%
126
-403
-76% -$107K
ERX icon
896
CALL
Direxion Daily Energy Bull 2X ETF
ERX
$244M
$28K ﹤0.01%
+2,900
New +$286K
LNT icon
897
Alliant Energy
LNT
$17.8B
$28K ﹤0.01%
583
-1,081
-65% -$59.2K
TQQQ icon
898
ProShares UltraPro QQQ
TQQQ
$36.7B
$28K ﹤0.01%
+4,696
New +$49.2K
WTFC icon
899
Wintrust Financial
WTFC
$10.9B
$28K ﹤0.01%
+867
New +$48.1K
X
900
CALL
DELISTED
US Steel
X
$28K ﹤0.01%
4,400
-100
-2% -$838
34 35
36
37 38

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.

  • Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
  • Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
  • Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
  • Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
  • Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
  • Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
  • Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.